Stephen Mitchener Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Stephen Mitchener is SVP, Chief Business Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 128,313 shares of KPTI, which is worth approximately $87,252. The most recent transaction as insider was on Mar 01, 2023, when has been sold 6,357 shares (Common Stock) at a price of $3.03 per share, resulting in proceeds of $19,261. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K

0% 3M change

0% 12M change

Total Value Held $87,252

Stephen Mitchener Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2023	SELL Open market or private sale	$19,261 $3.03 p/Share	6,357 Reduced 4.72%	128,313 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	60,000 Added 30.82%	134,670 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	20,000 Added 22.09%	70,546 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	47,250 Added 48.31%	50,546 Common Stock
Dec 02 2021	SELL Open market or private sale	$3,338 $6.69 p/Share	499 Reduced 13.15%	3,296 Common Stock
Jun 02 2021	SELL Open market or private sale	$4,905 $9.29 p/Share	528 Reduced 17.6%	2,472 Common Stock
May 30 2021	BUY Exercise of conversion of derivative security	-	1,500 Added 33.33%	3,000 Common Stock

Stephen Mitchener

SVP, Chief Business Officer

Newton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Value

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI

Account